I agree that this site is using cookies. You can find further informations here.
X
Zerda, I
26  results:
Search for persons X
?
1

EE49 Public Health Impact and Cost-Effectiveness of a New D..:

Shen, J ; Żerda, I ; Hanley, R...
Value in Health.  27 (2024)  6 - p. S66 , 2024
Link: https://doi.org/10.1016/..
 
?
2

EPH46 Validation of Dynamic Transmission Model for Varicell..:

Żerda, I. ; Fundament, T. ; Chełmikowski, F....
Value in Health.  26 (2023)  12 - p. S210-S211 , 2023
Link: https://doi.org/10.1016/..
 
?
3

EE471 Investigating the Impact of Pseudo-Random Numbers Gen..:

Dziedzic, J. ; Pochopien, M. ; Aballea, S....
Value in Health.  26 (2023)  12 - p. S142 , 2023
Link: https://doi.org/10.1016/..
 
?
4

EPH99 Public Health Impact of Replacing Monovalent and Quad..:

Żerda, I. ; Kłębczyk, W. ; Clay, E..
Value in Health.  26 (2023)  12 - p. S221 , 2023
Link: https://doi.org/10.1016/..
 
?
5

EE597 Data on Human Population Mobility in Individual-Based..:

Żerda, I. ; Fundament, T. ; Chełmikowski, F...
Value in Health.  26 (2023)  12 - p. S168 , 2023
Link: https://doi.org/10.1016/..
 
?
6

EE320 Impact of NASH Disease Model Adjustment to New Litera..:

Pochopien, M. ; Dziedzic, J. ; Clay, E....
Value in Health.  26 (2023)  12 - p. S112-S113 , 2023
Link: https://doi.org/10.1016/..
 
?
7

EE179 Key Drivers of the Economically Justifiable Price of ..:

Aballea, S ; Karwala, P ; Zerda, I...
Value in Health.  25 (2022)  7 - p. S368 , 2022
Link: https://doi.org/10.1016/..
 
?
8

EE174 Public Health Impact of Switching From a Trivalent to..:

Zerda, I ; Gorecki, M ; Clay, E...
Value in Health.  25 (2022)  12 - p. S87 , 2022
Link: https://doi.org/10.1016/..
 
?
9

EE247 Public Health Impact of Switching From a Trivalent to..:

Zerda, I ; Gorecki, M ; Clay, E...
Value in Health.  25 (2022)  12 - p. S102 , 2022
Link: https://doi.org/10.1016/..
 
?
10

EE283 Cost-Effectiveness Analysis of Cell-Based Therapy for..:

Aballea, S ; Karwala, P ; Zerda, I...
Value in Health.  25 (2022)  7 - p. S389 , 2022
Link: https://doi.org/10.1016/..
 
?
11

EPH161 Public Health Impact and Cost-Effectiveness Analysis..:

Jamet, N ; George, M ; Shah, HA...
Value in Health.  25 (2022)  12 - p. S221-S222 , 2022
Link: https://doi.org/10.1016/..
 
?
12

Haemorrhagic renal angiomyolipoma embolization:

El Aoufir, O. ; Zerda, I. ; Slaoui, A....
JMV-Journal de Médecine Vasculaire.  46 (2021)  5-6 - p. 254-257 , 2021
Link: https://doi.org/10.1016/..
 
?
13

PRM82 Verification of Proportional Hazards Assumption in Co..:

Zerda, I. ; Gwiosda, B. ; Plisko, R.
Value in Health.  15 (2012)  7 - p. A475 , 2012
Link: https://doi.org/10.1016/..
 
?
14

PRM80 Proportional Hazards Assumption and Its Impact on Res..:

Pochopien, M. ; Zerda, I. ; Gwiosda, B..
Value in Health.  15 (2012)  7 - p. A474 , 2012
Link: https://doi.org/10.1016/..
 
?
15

PND32 Cost-Utility Analysis of Ropinirole in Parkinson'S Di..:

Zerda, I. ; Drozdz, A. ; Brzyski, D....
Value in Health.  14 (2011)  7 - p. A323 , 2011
Link: https://doi.org/10.1016/..
 
1-15